Richard P. Slaughter Associates’s Biogen BIIB Stock Holding History

Richard P. Slaughter Associates’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,084	Closed	-$739K	–	134
2021 Q4	$739K	Sell	3,084 -1,512	-33%	-$389K	0.26%	98
2021 Q3	$1.3M	Buy	4,596 +3	+0.1%	+$983	0.52%	66
2021 Q2	$1.59M	Sell	4,593 -643	-12%	-$195K	0.61%	57
2021 Q1	$1.46M	Buy	5,236 +1,634	+45%	+$441K	0.61%	56
2020 Q4	$881K	Sell	3,602 -971	-21%	-$250K	0.37%	82
2020 Q3	$1.3M	Buy	4,573 +300	+7%	+$83.7K	0.59%	46
2020 Q2	$1.14M	Sell	4,273 -721	-14%	-$217K	0.5%	55
2020 Q1	$1.58M	Sell	4,994 -168	-3%	-$51K	0.83%	35
2019 Q4	$1.53M	Buy	+5,162	New	+$1.43M	0.61%	55

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Richard P. Slaughter Associates's BIIB Position: Q1 2022 in Review

Richard P. Slaughter Associates sold out of Biogen (BIIB) in Q1 2022, closing a stake of 3,084 shares — an estimated $739K sold.

Richard P. Slaughter Associates first reported a position in BIIB in Q4 2019 and held it in 9 quarters. The position peaked at $1.59M in Q2 2021. 951 funds tracked by Wall St. Rank hold BIIB as of Q1 2022.

Richard P. Slaughter Associates reported no remaining Biogen position as of Q1 2022 after selling out during the quarter.
Richard P. Slaughter Associates sold 3,084 Biogen shares in Q1 2022, an estimated $739K.
Richard P. Slaughter Associates first reported a position in Biogen in Q4 2019 and held it in 9 quarters.
Richard P. Slaughter Associates's Biogen position peaked at $1.59M in Q2 2021.
951 funds tracked by Wall St. Rank held Biogen as of Q1 2022.

Based on Richard P. Slaughter Associates's 13F filing for Q1 2022, filed 11 Apr 2022.